2026年3月最新《新锐期刊分区表》数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 新 聚合物期刊JPM征稿｜IF持续上升 + APC折扣 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Journal of Hematology & Oncology J HEMATOL ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.4
58人评分
我要评分
声誉 9.1 影响力 8.1 速度 6.9 | |||||||||||||||||||||||||||||||
| 期刊ISSN | 1756-8722 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 40.4 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：47.75 | |||||||||||||||||||||||||||||||
| 2024-2025自引率 | 1.0%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
| 五年影响因子 | 34.4 | |||||||||||||||||||||||||||||||
| JCI期刊引文指标 | 5.05 | |||||||||||||||||||||||||||||||
| h-index | 60 | |||||||||||||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||||
| 期刊官方网站 | http://jhoonline.biomedcentral.com | |||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||
| 期刊投稿网址 | https://www.springer.com/12481 | |||||||||||||||||||||||||||||||
| 作者指南网址 | http://jhoonline.biomedcentral.com/submission-guidelines | |||||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | CAR-T therapy moving to first-line in multiple myeloma: latest updates from the 2025 ASH annual meeting Author: Geng, Chuanying; Chen, Wenming; Zhu, Hong-Hu Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01793-8 Agent-specific, histopathology-stratified hematologic malignancy risk among dpp-4 inhibitors, glp-1 receptor agonists, and SGLT2 inhibitors: a network meta-analysis of 270,471 participants Author: Lin, Pao-Yen; Zeng, Bing-Syuan; Chen, Jiann-Jy; Zeng, Bing-Yan; Suen, Mein-Woei; Hung, Chao-Ming; Hsu, Chih-Wei; Stubbs, Brendon; Chen, Yen-Wen; Chen, Tien-Yu; Lei, Wei-Te; Hsu, Shih-Pin; Shiue, Yow-Ling; Su, Kuan-Pin; Li, Cheng-Ta; Wang, Hung-Yu; Tseng, Ping-Tao; Liang, Chih-Sung Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01788-5 In vivo CAR-T cell therapy: latest updates from 2025 ASH annual meeting Author: Gao, Pan; Liu, Jun; Ma, Jun; Ma, Hengrui; Zhang, Ya Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01787-6 Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: results from a randomized, multicenter, placebo-controlled phase 3 trial Author: Wu, Runhui; Gao, Ju; Liu, Yufeng; Yu, Jie; Hu, Shaoyan; Liang, Hui; Jiang, Hui; Zhai, Xiaowen; Zhou, Min; Hao, Wenge; Mei, Heng; Li, Fei; Chen, Yumei; Liu, Wei; Yan, Mei; Li, Runzi; Xiong, Junye; Zhu, Zhenyi; Cheng, Xiaoling; Wang, Tianyou Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01790-x | |||||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Journal of Hematology & Oncology的语言要求，还能让Journal of Hematology & Oncology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Journal of Hematology & Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评（1篇） 论文致谢（6篇） 。
提交文稿 | |||||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ GBP3390; USD4690; EUR3990; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：haematology、oncology 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||||||||
| 通讯方式 | BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL | |||||||||||||||||||||||||||||||
| 出版商 | BioMed Central | |||||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-血液学 | |||||||||||||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||
| 出版周期 | Irregular | |||||||||||||||||||||||||||||||
| 出版年份 | 2008 | |||||||||||||||||||||||||||||||
| 年文章数 | 79点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
| Gold OA文章占比 | 100.00% | |||||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 41.77% | |||||||||||||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-8722%5BISSN%5D | |||||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 较慢,6-12周 | |||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ GBP3390; USD4690; EUR3990; ） 文章处理费豁免：查看说明 其他费用：没有 LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Journal of Hematology & Oncology顺利发表。
快看看作者怎么说吧：服务好评（1篇） 论文致谢（6篇） 。 提交文稿 | |||||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | CAR-T therapy moving to first-line in multiple myeloma: latest updates from the 2025 ASH annual meeting Author: Geng, Chuanying; Chen, Wenming; Zhu, Hong-Hu Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01793-8 PubMed DOI |
| 2. | Agent-specific, histopathology-stratified hematologic malignancy risk among dpp-4 inhibitors, glp-1 receptor agonists, and SGLT2 inhibitors: a network meta-analysis of 270,471 participants Author: Lin, Pao-Yen; Zeng, Bing-Syuan; Chen, Jiann-Jy; Zeng, Bing-Yan; Suen, Mein-Woei; Hung, Chao-Ming; Hsu, Chih-Wei; Stubbs, Brendon; Chen, Yen-Wen; Chen, Tien-Yu; Lei, Wei-Te; Hsu, Shih-Pin; Shiue, Yow-Ling; Su, Kuan-Pin; Li, Cheng-Ta; Wang, Hung-Yu; Tseng, Ping-Tao; Liang, Chih-Sung Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01788-5 PubMed DOI |
| 3. | In vivo CAR-T cell therapy: latest updates from 2025 ASH annual meeting Author: Gao, Pan; Liu, Jun; Ma, Jun; Ma, Hengrui; Zhang, Ya Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01787-6 PubMed DOI |
| 4. | Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: results from a randomized, multicenter, placebo-controlled phase 3 trial Author: Wu, Runhui; Gao, Ju; Liu, Yufeng; Yu, Jie; Hu, Shaoyan; Liang, Hui; Jiang, Hui; Zhai, Xiaowen; Zhou, Min; Hao, Wenge; Mei, Heng; Li, Fei; Chen, Yumei; Liu, Wei; Yan, Mei; Li, Runzi; Xiong, Junye; Zhu, Zhenyi; Cheng, Xiaoling; Wang, Tianyou Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01790-x PubMed DOI |
| 5. | CXCR4-antagonistic peptide-decorated lipid nanoparticles for co- delivery of AML1-ETO siRNA to enhance chemotherapy in refractory AML Author: Peng, Xuelu; Gu, Runxia; Wang, Tao; Jiang, Chuanmei; Xing, Haiyan; Meng, Jie; Wen, Tao; Liu, Jian; Wang, Jianxiang; Xu, Haiyan Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01785-8 PubMed DOI |
| 6. | IL-5 CAR-T cell therapy induces effective remission in hypereosinophilic disorders Author: Wu, Youqian; Zhang, Ruiqi; Sun, Beibei; Chen, Gaoying; Xu, Fang; Chen, Xinyi; Zeng, Jiayuan; Shen, Dan; Shi, Fan; Pan, Sheng; Yao, Bingpeng; Tang, Haoyu; Shao, Zhehua; Wu, Qian; Shao, Jiawei; Zhang, Chao; Wang, Dongrui; Hu, Yongxian; Ying, Songmin Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01782-x PubMed DOI |
| 7. | The distinct roles of ROS in tumor immunity: from mechanisms to immunotherapeutic applications Author: Li, Jiayi; Huang, Chen; Tang, Pan; Wu, Ruiyan; Wu, Quanyou; Zhang, Chenliang Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01780-z PubMed DOI |
| 8. | CBX3 confers ferroptosis resistance during blood-borne metastasis Author: Wu, Chun; Liu, Xuefei; Zhao, Boxi; Zhao, Mao; Zhang, Binyu; Huang, Guanyin; Cheng, Yixin; Zheng, Shuqian; Hu, Jianyang; Guo, Ling; Guo, Weinan; Tan, Jun; Hong, Xin Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-025-01777-0 PubMed DOI |
| 9. | Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution Author: Liu, Chunliang; Wang, Xiang; Liu, Erdong; Zong, Yali; Yu, Wenlong; Jiang, Youhai; Chen, Jianan; Gu, Mingye; Meng, Zhengyuan; Li, Jingfeng; Liu, Yang; Zhang, Yongjie; Tang, Jing; Wang, Hongyang; Fu, Jing Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2025; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13045-025-01716-z PubMed DOI |
| 10. | Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy Author: Hu, Qin; Zhu, Yifei; Mei, Jie; Liu, Ying; Zhou, Guoren Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2025; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13045-025-01717-y PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共5条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
